Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is more effective than pelvic floor muscle training for improving quality of life in women with stress urinary incontinence.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Platelet-rich plasma shows promise for treating dry eye disease, but more standardized trials are needed.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Biosimilars lower costs but don't significantly improve access.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Provenge extends prostate cancer survival by about 4 months.

Platelet-rich plasma speeds up early skin wound healing.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Platelet-rich plasma (PRP) treatments are not effective.

Targeting PTEN can improve healing in venous leg ulcers.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

The new controlled release PRP therapy shows promise for hair growth in women.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

PRS injections can improve knee function and reduce pain for up to a year.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

PRP shows promise in musculoskeletal rehabilitation but needs standardized reporting for better outcomes.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Ice cooling and vibration can reduce pain during PRP scalp injections without affecting treatment effectiveness.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.